Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
173.30
+0.73 (0.42%)
At close: Mar 6, 2026, 4:00 PM EST
174.49
+1.19 (0.69%)
After-hours: Mar 6, 2026, 5:57 PM EST
Belite Bio Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Belite Bio stock have an average target of 181.14, with a low estimate of 80 and a high estimate of 266. The average target predicts an increase of 4.52% from the current stock price of 173.30.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Belite Bio stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 2 | 3 | 4 | 4 | 4 |
| Hold | 0 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $185 → $200 | Strong Buy | Maintains | $185 → $200 | +15.41% | Mar 3, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $191 → $201 | Buy | Maintains | $191 → $201 | +15.98% | Mar 3, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $266 | Buy | Maintains | $200 → $266 | +53.49% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $185 | Strong Buy | Reiterates | $185 | +6.75% | Jan 28, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $195 | Strong Buy | Initiates | $195 | +12.52% | Jan 26, 2026 |
Financial Forecast
Revenue This Year
43.71M
Revenue Next Year
139.19M
from 43.71M
Increased by 218.41%
EPS This Year
-1.26
from -2.31
EPS Next Year
-1.94
from -1.26
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 262.5M | 174.2M | |||
| Avg | 43.7M | 139.2M | |||
| Low | n/a | 57.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 298.4% | |||
| Avg | - | 218.4% | |||
| Low | - | 32.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.33 | -0.11 | |||
| Avg | -1.26 | -1.94 | |||
| Low | -2.98 | -3.64 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.